1 min read
Theriva Biologics Sets 1-for-30 Reverse Split for Dec. 1, 2026
The split will take effect after the market closes, with shares scheduled to begin split-adjusted trading Dec. 2.

Theriva Biologics (TOVX) announced a 1-for-30 reverse stock split scheduled to take effect after the market closes Dec. 1, 2026. The company’s shares are set to begin trading on a split-adjusted basis Dec. 2.
Under the announced ratio, every 30 existing shares will be combined into one share. The change is scheduled to take effect after the market closes on Dec. 1.